- Report
- December 2024
- 200 Pages
Global
From €3521EUR$3,750USD£2,937GBP
- Report
- December 2024
- 200 Pages
Global
From €3521EUR$3,750USD£2,937GBP
- Report
- October 2024
- 200 Pages
Global
From €3521EUR$3,750USD£2,937GBP
- Report
- October 2024
- 200 Pages
Global
From €3521EUR$3,750USD£2,937GBP
- Report
- May 2024
- 200 Pages
Global
From €3896EUR$4,150USD£3,251GBP
- Report
- January 2024
- 200 Pages
Global
From €3896EUR$4,150USD£3,251GBP
- Report
- July 2025
- 180 Pages
Global
From €4225EUR$4,500USD£3,525GBP
- Report
- July 2024
- 82 Pages
Japan
From €3286EUR$3,500USD£2,742GBP
- Report
- May 2024
- 183 Pages
Global
From €4225EUR$4,500USD£3,525GBP
- Report
- April 2023
- 120 Pages
Global
From €4460EUR$4,750USD£3,721GBP
- Report
- July 2025
- 350 Pages
Global
From €4647EUR$4,949USD£3,877GBP
- Report
- April 2023
- 147 Pages
Global
From €4647EUR$4,949USD£3,877GBP
- Report
- June 2025
- 172 Pages
Global
From €4225EUR$4,500USD£3,525GBP
- Report
- June 2025
- 400 Pages
Global
From €4647EUR$4,949USD£3,877GBP
- Report
- June 2025
- 400 Pages
Global
From €4647EUR$4,949USD£3,877GBP
- Report
- June 2025
- 400 Pages
Global
From €4647EUR$4,949USD£3,877GBP
- Report
- August 2024
- 200 Pages
Global
From €4647EUR$4,949USD£3,877GBP
- Report
- July 2024
- 171 Pages
Global
From €4225EUR$4,500USD£3,525GBP
- Report
- May 2026
- 90 Pages
China
From €2676EUR$2,850USD£2,232GBP
- Report
- June 2025
- 141 Pages
Global
From €3709EUR$3,950USD£3,094GBP

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more